Novavax Inc
NASDAQ:NVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novavax Inc
NASDAQ:NVAX
|
US |
|
A
|
Adidas AG
OTC:ADDDF
|
DE |
|
S
|
Sandoz Group AG
OTC:SDZNY
|
CH |
|
FirstRand Ltd
F:FSR
|
ZA |
|
Galapagos NV
OTC:GLPGF
|
BE |
|
Petershill Partners PLC
LSE:PHLL
|
UK |
|
P
|
Pulsar Helium Inc
XTSX:PLSR
|
CA |
|
J
|
Jacobs Engineering Group Inc
F:JEG
|
US |
|
Aspen Technology Inc
NASDAQ:AZPN
|
US |
|
International Consolidated Airlines Group SA
LSE:IAG
|
UK |
Wall St Price Targets
NVAX Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for NVAX is 14.393 USD with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVAX's stock price target?
Price Target
14.393
USD
According to Wall Street analysts, the average 1-year price target for NVAX is 14.393 USD with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Novavax Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Novavax Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 8 years is 2%.
What is the Net Income forecast for Novavax Inc?
Projected CAGR
-22%
The compound annual growth rate for Net Income over the next 7 years is -22%.
